Proposed 21st wave technology appraisals
| Topic | Renal transplantation (organ rejection) - belatacept |
|---|---|
|
Scoping workshop - Change of date notification The National Institute for Health and Clinical Excellence has been invited to carry out the appraisals of belatacept for the prevention of organ rejection in renal transplantation and everolimus for the prevention of organ rejection in renal transplantation We have recently sent out invitations to consultees and commentators to a scoping workshop for these proposed appraisals for Wednesday 3rd June 2009. We have been advised that the British Renal Society is holding its annual conference from Monday 1st June - Wednesday 3rd June 2009. As the last day of the conference coincides with the date of the scoping workshop it may mean we have a limited number of people interested in renal disease who will be able to attend and contribute to the scoping workshop. In light of this information the Institute has taken the decision to rearrange the scoping workshop to be held on Tuesday 9 June 2009 at the NICE offices in central London. We hope that this will enable those stakeholders who otherwise would have been unable to attend the scoping workshop due to the conflicting date with the British Renal Society’s annual conference to attend and provide their valuable knowledge and opinions. If you have any comments or concerns please do not hesitate on 0161 870 3155 or email jenniffer.alty@nice.org.uk |
|
| Suggested remit | To appraise the clinical and cost effectiveness of belatacept within its licensed indication for the prevention of organ rejection in renal transplantation |
| Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators | Tuesday 14 April 2009 - Wednesday 13 May 2009 |
| Scoping workshop | Tuesday 9 June 2009 (morning meeting) in central London |
| Enquiries to | jenniffer.alty@nice.org.uk |
| Consultation document(s) | |
| Topic | Established renal failure - tap water home haemodialysis systems |
|---|---|
|
Scoping workshop - Change of date notification The Department of Health has invited the National Institute for Health and Clinical Excellence to carry out the appraisal of tap water haemodialysis systems for established renal failure as part of the 21st wave work programme. We have recently sent out invitations to consultees and commentators to a scoping workshop for this proposed appraisal for Wednesday 3rd June 2009. We have been advised that the British Renal Society is holding its annual conference from Monday 1st June - Wednesday 3rd June 2009. As the last day of the conference coincides with the date of the scoping workshop it may mean we have a limited number of people interested in renal disease who will be able to attend and contribute to the scoping workshop. In light of this information the Institute has taken the decision to rearrange the scoping workshop to be held on Tuesday 9 June 2009 at the NICE offices in central London. We hope that this will enable those stakeholders who otherwise would have been unable to attend the scoping workshop due to the conflicting date with the British Renal Society’s annual conference to attend and provide their valuable knowledge and opinions. If you have any comments or concerns, please do not hesitate to contact the Scoping Programme Manager on 0161 870 3155 or email jenniffer.alty@nice.org.uk |
|
| Suggested remit | To appraise the clinical and cost effectiveness of tap water haemodialysis system within its indications for use for the treatment of established renal failure. |
| Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators | Tuesday 14 April 2009 - Wednesday 13 May 2009 |
| Scoping workshop | Tuesday 9 June 2009 (afternoon meeting) in central London |
| Enquiries to | jenniffer.alty@nice.org.uk |
| Consultation document(s) | |
| Topic | Renal transplantation (organ rejection) - everolimus | |
|---|---|---|
|
Scoping workshop - Change of date notification The Department of Health has invited the National Institute for Health and Clinical Excellence to carry out the appraisal of tap water haemodialysis systems for established renal failure as part of the 21st wave work programme. We have recently sent out invitations to consultees and commentators to a scoping workshop for this proposed appraisal for Wednesday 3rd June 2009. We have been advised that the British Renal Society is holding its annual conference from Monday 1st June - Wednesday 3rd June 2009. As the last day of the conference coincides with the date of the scoping workshop it may mean we have a limited number of people interested in renal disease who will be able to attend and contribute to the scoping workshop. In light of this information the Institute has taken the decision to rearrange the scoping workshop to be held on Tuesday 9 June 2009 at the NICE offices in central London. We hope that this will enable those stakeholders who otherwise would have been unable to attend the scoping workshop due to the conflicting date with the British Renal Society’s annual conference to attend and provide their valuable knowledge and opinions. If you have any comments or concerns, please do not hesitate to contact the Scoping Programme Manager on 0161 870 3155 or email jenniffer.alty@nice.org.uk |
||
| Suggested remit | To appraise the clinical and cost effectiveness of everolimus within its licensed indication for the prevention of organ rejection in renal transplantation | |
| Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators | Wednesday 15 April 2009 - Thursday 14 May 2009 | |
| Scoping workshop | Tuesday 9 June 2009 (morning meeting) in central London | |
| Enquiries to | jenniffer.alty@nice.org.uk | |
| Consultation document(s) | ||
| Topic | Heart failure (acute) - rolofylline |
|---|---|
| Suggested remit | To appraise the clinical and cost effectiveness of rolofylline for the treatment of acute heart failure within its licensed indications. |
| Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators | Tuesday 7 April 2009 - Friday 8 May 2009 |
| Scoping workshop | Monday 1 June 2009 (afternoon meeting) in central London |
| Enquiries to | jenniffer.alty@nice.org.uk |
| Consultation document(s) |
| Topic | Cardiac transplantation (organ rejection) - everolimus |
|---|---|
| Suggested remit | To appraise the clinical and cost-effectiveness of everolimus for the prevention of organ rejection in cardiac transplantation within its licensed indication. |
| Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators | Friday 3 April 2009 - Wednesday 6 May 2009 |
| Scoping workshop | Wednesday 20 May 2009 (afternoon meeting) central Manchester |
| Enquiries to | jenniffer.alty@nice.org.uk |
| Consultation document(s) |
| Topic | Hepatitis B (decompensated liver disease) - entecavir |
|---|---|
| Suggested remit | To appraise the clinical and cost effectiveness of entecavir within its licensed indication for the treatment of chronic hepatitis B in adults with decompensated liver disease. |
| Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators | Friday 3 April 2009 - Wednesday 6 May 2009 |
| Scoping workshop | Monday 18 May 2009 (morning meeting) in central London |
| Enquiries to | jenniffer.alty@nice.org.uk |
| Consultation document(s) |